Literature DB >> 19075531

[Pharmacological profiles and clinical effects of blonanserin (Lonasen) on schizophrenia].

Tadashi Ishibashi1, Hiroyuki Nishikawa, Teruaki Une, Hiroshi Nakamura.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2008        PMID： 19075531     DOI： 10.1254/fpj.132.351

Source DB:  PubMed          Journal:  Nihon Yakurigaku Zasshi        ISSN： 0015-5691


× No keyword cloud information.
  2 in total

1.  Blonanserin - A Novel Antianxiety and Antidepressant Drug? An Experimental Study.

Authors:  Ramchandra Prabhakar Limaye; Aditi Nitin Patil
Journal:  J Clin Diagn Res       Date:  2016-09-01

2.  Cardiometabolic risks of blonanserin and perospirone in the management of schizophrenia: a systematic review and meta-analysis of randomized controlled trials.

Authors:  Taro Kishi; Yuki Matsuda; Nakao Iwata
Journal:  PLoS One       Date:  2014-02-04       Impact factor: 3.240
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.